Search Results - "Kernan, N.A"

Excellent outcomes of combined umbilical cord blood and bone marrow grafts for allogeneic transplantation of pediatric patients from HLA-matched siblings. a single institution experience by Boulad, F, Scaradavou, A, Avecilla, S.T, Tonon, J, Kernan, N.A, Prockop, S.E, Klein, E, Boelens, J.J

“…Background & AimWe hypothesized that combining cord blood (CB) and bone marrow (BM) grafts from HLA-identical siblings would improve the outcome of allogeneic…”
Get full text

Work-up for infectious diarrhea after allogeneic hematopoietic stem cell transplantation: single specimen testing results in cost savings without compromising diagnostic yield by Kamboj, M., Mihu, C.N., Sepkowitz, K., Kernan, N.A., Papanicolaou, G.A.

“…: Background. Diarrhea is a common complication of allogeneic bone marrow transplantation. Microbiologic stool studies are frequently ordered to rule out…”
Get full text

Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation Has Unique Features and an Association with Engrafting Unit-to-Recipient HLA Match by Ponce, D.M, Gonzales, A, Lubin, M, Castro-Malaspina, H, Giralt, S, Goldberg, J.D, Hanash, A.M, Jakubowski, A, Jenq, R, Papadopoulos, E.B, Perales, M.A, van den Brink, M.R.M, Young, J.W, Boulad, F, O'Reilly, R.J, Prockop, S, Small, T.N, Scaradavou, A, Kernan, N.A, Stevens, C.E, Barker, J.N

“…Abstract Manifestations of and risk factors for graft-versus-host disease (GVHD) after double-unit cord blood transplantation (DCBT) are not firmly…”
Get full text

Allogeneic Stem Cell Transplantation for Sickle Cell Anemia (SCA) at MSKCC: A Single Institution Series by Anur, P, Sklar, C, Kernan, N.A, Prockop, S.E, Scaradavou, A, Small, T.N, O'Reilly, R.J, Boulad, F

Get full text

Safety and Effectiveness of Intravenous Palivizumab for Prevention of Respiratory Syncytial Virus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation by Small, T.N, Kernan, N.A, Boulad, F, Prockop, S.E, Scaradavou, A, Kobos, R, Zakak, N, Ruggiero, J, O'Reilly, R.J

Get full text

Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors by Anur, P, Friedman, D N, Sklar, C, Oeffinger, K, Castiel, M, Kearney, J, Singh, B, Prockop, S E, Kernan, N A, Scaradavou, A, Kobos, R, Curran, K, Ruggiero, J, Zakak, N, O'Reilly, R J, Boulad, F

“…Hematopoietic stem cell transplantation (HSCT) is curative for hematological manifestations of Fanconi anemia (FA). We performed a retrospective analysis of 22…”
Get full text

Fludarabine Based Preparative Regimen Can Secure a Second Hematopoietic Stem Cell Transplant After Initial Graft Rejection by Tamari, R, Boulad, F, Papadopoulos, E.B, Kernan, N.A, Jakubowski, A, Small, T.N, Perales, M.A, O'Reilly, R.J, Young, J.W, Giralt, S, Barker, J, Castro Malaspina, H

Get full text

“No Wash” Albumin-Dextran Dilution for Double-Unit Cord Blood Transplantation (DCBT) Is Safe with Appropriate Management and Results in High Rates of Sustained Donor Engraftment by Dahi, P.B, Lubin, M.N, Evans, K.L, Gonzales, A.M.R, Schaible, A, Tonon, J, Heller, G, Ponce, D.M, Kernan, N.A, Scaradavou, A, Barker, J.N

Get full text

Graft-Versus-Host Disease (GVHD) After Double-Unit Cord Blood Transplantation (DCBT) Is Associated with Unique Clinical Features Including a Higher Incidence of Grade III-IV Acute GVHD (aGVHD) in Children by Ponce, D.M, Gonzales, A.M.R, Lubin, M.N, Castro-Malaspina, H, Geralt, S.A, Goldberg, J.D, Jakubowski, A.A, Papadopoulos, E.B, Perales, M.-A, van den Brink, M.R.M, Young, J.W, Kernan, N.A, O'Reilly, R.J, Prockop, S.E, Scaradavou, A, Stevens, C.E, Barker, J.N

Get full text

Successful Treatment of Acute Gastrointestinal (GI) Graft-Versus-Host Disease (GVHD) After Cord Blood Transplantation (CBT) With Single Agent Budesonide by Ponce, D.M, Gonzales, A.M, Lubin, M, Heller, G, Perales, M.-A, Castro-Malaspina, H, Giralt, S, Jakubowski, A, Papadopoulos, E, Scaradavou, A, Kernan, N.A, Barker, J.N

Get full text

Total Donor Chimerism in the Day 21 Bone Marrow Predicts Sustained Donor Neutrophil Engraftment Following Double Unit Cord Blood Transplantation (CBT) by Avery, S, Voss, M.H, Gonzales, A.M, Lubin, M, Castro-Malaspina, H, Kernan, N.A, Scaradavou, A, Hedvat, C, Stevens, C.E, Barker, J.N

Get full text

Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients by Barker, J.N, Ponce, D.M, Gonzales, A.M.R, Lubin, M.N, Castro-Malaspina, H, Giralt, S.A, Goldberg, J.D, Jakubowski, A.A, Koehne, G, Papadopoulos, E.B, Perales, M.-A, Sauter, C.S, van den Brink, M.R.M, Young, J.W, Boulad, F, Kobos, R, O'Reilly, R.J, Prockop, S.E, Small, T.N, Stevens, C.E, Kernan, N.A, Scaradavou, A

Get full text

Long-Term Survival After T-Cell Depleted Allogeneic Stem Cell Transplantation in Patients With Acute Lymphoblastic Leukemia by Linker, A, Goldberg, J.D, Ratan, R, Jurcic, J, Barker, J.N, Castro-Malaspina, H, Jakubowski, A.A, Jenq, R, Koehne, G, Papadopoulos, E, van den Brink, M.R.M, Young, J.W, Boulad, F, Kernan, N.A, O'Reilly, R.J, Small, T.N, Heller, G, Perales, M.-A

Get full text

Clofarabine Melphalan and Thiotepa Followed by Unmodified Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Treatment of High-Risk or Advanced Acute Leukemia by Boulad, F, Kernan, N.A, Prockop, S.E, Scaradavou, A, Small, T.N, Jakubowski, A, Papadopoulos, E, Perales, M.A

Get full text

Cord Blood (CB) Extends Transplant Access to Racial and Ethnic Minorities: A Prospective Study of 309 Unrelated Searches in Patients with High-Risk Hematologic Malignancies by Lee, S.S, Scaradavou, A, Hawke, R.M, Webb, K.A, Wells, D.S, Abboud, M, Papadopoulos, E.B, Kernan, N.A, Barker, J.N

Get full text

Adoptive Transfer Of EBV Specific T-Cells For Treatment Of Primary And Rituxan Resistant EBV Lymphomas Following Allogeneic Stem Cell Transplants (HSCT): Clinical, Viral And Immunologic Corelates by Doubrovina, E, Oflaz-Sozmen, B, Kernan, N.A, Young, J, Abramson, S, Barker, J, Boulad, F, Castro-Malaspina, H, Teruya-Feldstein, J, Filippa, D, Jakubowski, A, Papadopoulos, E.B, Prockop, S, Scaradavou, A, Small, T, O'Reilly, R.J

Get full text

209: Practice variation in supportive care in hematopoietic cell transplantation by Lee, S.J, Eapen, M, Soiffer, R.J, McCarthy, P.L, Loberiza, F, Kernan, N.A, Jagasia, M, Davies, S, Artz, A, Joffe, S

Get full text

Donor–recipient allele-level HLA matching of unrelated cord blood units reveals high degrees of mismatch and alters graft selection by Dahi, P B, Ponce, D M, Devlin, S, Evans, K L, Lubin, M, Gonzales, A M, Byam, C, Sideroff, M, Wells, D, Giralt, S, Kernan, N A, Scaradavou, A, Barker, J N

“…The feasibility of selecting cord blood (CB) units at high-resolution HLA match has not been investigated. We analyzed the high-resolution donor–recipient HLA…”
Get full text

Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease by PERALES, M.-A, ISHILL, N, JAKUBOWSKI, A. A, O'REILLYL, R. J, SMALL, T. N, YOUNG, J. W, KERNAN, N. A, LOMAZOW, W. A, WEINSTOCK, D. M, PAPADOPOULOS, E. B, DASTIGIR, H, CHIU, M, BOULAD, F, CASTRO-MALASPINA, H. R, HELLER, G

“…Daclizumab has been shown to have activity in acute GVHD, but appears to be associated with an increased risk of infection. To investigate further the…”
Get full text

T-cell-depleted hematopoietic SCT from unrelated donors for the treatment of congenital amegakaryocytic thrombocytopenia by Tarek, N, Kernan, N A, Prockop, S E, Scaradavou, A, Small, T N, O'Reilly, R J, Boulad, F

“…10/10 TBI: 125 cGy TID 9/10 (A Mel: 60 mg/[m.sup.2]/d x…”
Get full text